Literature DB >> 21036679

A highly sensitive ultra performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS) technique for quantitation of protein free and bound efavirenz (EFV) in human seminal and blood plasma.

Lindsay B Avery1, Teresa L Parsons, David J Meyers, Walter C Hubbard.   

Abstract

A combined UPLC-tandem mass spectrometric (UPLC-MS/MS) technique has been validated for quantitation of protein free efavirenz (EFV) as well as total concentrations of EFV in human blood and seminal plasma. The analytical method possesses capabilities for concentration measurements of EFV ranging from 0.5 to 10,000ng/ml with an accuracy (%dev) of -5.2-8.0% and precision (%CV) of <8%. Standard curves were linear with coefficients of variation (r(2)) >0.98. The method employs a racemic fluorinated analog of EFV (F-EFV) as the internal standard. EFV and F-EFV were eluted from a reverse-phase UPLC column via gradient elution with detection via negative ion multiple reaction monitoring (MRM). EFV and F-EFV, respectively, were detected via the following MRM transitions: m/z 314.0>244.1 and m/z 298.0>227.9. The time required for the analysis of each sample was 8.0min. The analytical technique is capable of a reliable detection limit of ∼15-20fmol of EFV injected on column.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036679      PMCID: PMC3000541          DOI: 10.1016/j.jchromb.2010.09.011

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  13 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Simple and rapid liquid chromatography method for determination of efavirenz in plasma.

Authors:  Geetha Ramachandran; A K Hemanth Kumar; Soumya Swaminathan; P Venkatesan; V Kumaraswami; David J Greenblatt
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-03-29       Impact factor: 3.205

3.  Effect of semen sampling frequency on seminal antiretroviral drug concentration.

Authors:  Y J Cao; T T Ndovi; T L Parsons; A M Guidos; B Caffo; C W Hendrix
Journal:  Clin Pharmacol Ther       Date:  2007-10-03       Impact factor: 6.875

Review 4.  Male genital tract pharmacology: developments in quantitative methods to better understand a complex peripheral compartment.

Authors:  Y-J Cao; C W Hendrix
Journal:  Clin Pharmacol Ther       Date:  2007-10-05       Impact factor: 6.875

Review 5.  Sexual transmission of HIV.

Authors:  R A Royce; A Seña; W Cates; M S Cohen
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

6.  Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood.

Authors:  R W Coombs; C E Speck; J P Hughes; W Lee; R Sampoleo; S O Ross; J Dragavon; G Peterson; T M Hooton; A C Collier; L Corey; L Koutsky; J N Krieger
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

7.  Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.

Authors:  Y Sunila Reddy; S Karl Gotzkowsky; Joseph J Eron; Julie Y Kim; William D Fiske; Susan A Fiscus; Leslie Petch; Myron S Cohen; Angela D M Kashuba
Journal:  J Infect Dis       Date:  2002-10-07       Impact factor: 5.226

8.  Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA).

Authors:  M Patel; R J McHugh; B C Cordova; R M Klabe; S Erickson-Viitanen; G L Trainor; S S Ko
Journal:  Bioorg Med Chem Lett       Date:  1999-11-15       Impact factor: 2.823

9.  4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.

Authors:  A J Cocuzza; D R Chidester; B C Cordova; R M Klabe; S Jeffrey; S Diamond; C A Weigelt; S S Ko; L T Bacheler; S K Erickson-Viitanen; J D Rodgers
Journal:  Bioorg Med Chem Lett       Date:  2001-06-04       Impact factor: 2.823

Review 10.  Protein binding in antiretroviral therapies.

Authors:  Marta Boffito; David J Back; Terrence F Blaschke; Malcolm Rowland; Richard J Bertz; John G Gerber; Veronica Miller
Journal:  AIDS Res Hum Retroviruses       Date:  2003-09       Impact factor: 2.205

View more
  8 in total

1.  The male genital tract is not a pharmacological sanctuary from efavirenz.

Authors:  L B Avery; R P Bakshi; Y J Cao; C W Hendrix
Journal:  Clin Pharmacol Ther       Date:  2011-06-01       Impact factor: 6.875

2.  HIV Care Continuum for HIV-Infected Emergency Department Patients in an Inner-City Academic Emergency Department.

Authors:  Yu-Hsiang Hsieh; Gabor D Kelen; Oliver Laeyendecker; Chadd K Kraus; Thomas C Quinn; Richard E Rothman
Journal:  Ann Emerg Med       Date:  2015-02-23       Impact factor: 5.721

3.  Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration.

Authors:  L B Avery; N Sacktor; J C McArthur; C W Hendrix
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

4.  Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid.

Authors:  Lindsay B Avery; Jennifer L VanAusdall; Craig W Hendrix; Namandjé N Bumpus
Journal:  Drug Metab Dispos       Date:  2012-11-19       Impact factor: 3.922

5.  Improvements in the continuum of HIV care in an inner-city emergency department.

Authors:  Gabor D Kelen; Yu-Hsiang Hsieh; Richard E Rothman; Eshan U Patel; Oliver B Laeyendecker; Mark A Marzinke; William Clarke; Teresa Parsons; Jordyn L Manucci; Thomas C Quinn
Journal:  AIDS       Date:  2016-01-02       Impact factor: 4.177

6.  Increasing extracellular protein concentration reduces intracellular antiretroviral drug concentration and antiviral effect.

Authors:  Lindsay B Avery; Melissa A Zarr; Rahul P Bakshi; Robert F Siliciano; Craig W Hendrix
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-22       Impact factor: 2.205

7.  Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz.

Authors:  Luis B Tovar-y-Romo; Namandjé N Bumpus; Daniel Pomerantz; Lindsay B Avery; Ned Sacktor; Justin C McArthur; Norman J Haughey
Journal:  J Pharmacol Exp Ther       Date:  2012-09-13       Impact factor: 4.030

Review 8.  Antiretroviral bioanalysis methods of tissues and body biofluids.

Authors:  Robin DiFrancesco; Getrude Maduke; Rutva Patel; Charlene R Taylor; Gene D Morse
Journal:  Bioanalysis       Date:  2013-02       Impact factor: 2.681

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.